Stay updated on Ampyra Optic Neuritis in MS Clinical Trial

Sign up to get notified when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ampyra Optic Neuritis in MS Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:18:35.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 crossover study testing dalfampridine (Ampyra) for visual impairment after optic neuritis in people with multiple sclerosis. It includes study eligibility and treatment details, outcome measures, investigators, publications, and results-related record dates.
    Difference
    55%
    Check dated 2026-11-10T20:48:48.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer now identifies the platform as revision v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than study details.
    Difference
    0.2%
    Check dated 2026-11-03T21:32:14.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A banner about NIH website changes was added, and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:01:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T22:03:30.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A broad set of MeSH terms and keywords tied to the study topic were removed from the record, affecting how the study is categorized and found in searches.
    Difference
    19%
    Check dated 2026-09-22T22:56:10.000Z thumbnail image

Stay in the know with updates to Ampyra Optic Neuritis in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.